1Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop[J]. Hum Pathol,2001;32:578-582.
2Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics[J]. Pol J Pathol, 2003,54(1) :3-24.
3Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract[J]. Histol Histopathol,2000,15:1293-1301.
4De Matteo RP, Lewis JJ, Leung D. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival[J]. Ann Sug,2000,231:51-58.
5Mazur MT, Clark HB. Gastric stromal turmors: reappraisal of histrogenesis[J]. Am J Surg Pathol, 1983,7(16): 507-519.
6Heinrich MC, Blanke CD, Druker BJ, et al. Inhibition of KIT tyrosine kinase activity. A novel molecular approach to the treatment of KIT-positive malignancies[J]. J Clin Oncol,2002,20:1692-1703.
7Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables[J]. Ann Surg Oncol,1995,2(1) :26-31.
8Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors[J]. J Clin Oncol,2002,20:3898-3905.
9Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors (abstract) [J]. Science, 2003, 299: 708-710.
10Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations[J]. Hum Pathol, 2002,33:484-495.
8Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, Clinical, Histological, Immunohistoche mical, and molecular genetic features and differential diagnosis. Virchows Arch ,2001,438 : 1-12.
9Mazur MT, Clark HB. Gastric stromal tumors : reappraisal of histrogenesis. Am J Surg Pathol, 1983,7:507-519.
10Dematteo Bplewis JJ, Leung D, et al. Two Hundred gastrointestinal stromal tumors:recurrence patterna and prognostic factors for survival. Aann Surg,2000,231:51-58.
